Welcome to our dedicated page for Fitlife Brands SEC filings (Ticker: FTLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for FitLife Brands, Inc. (NASDAQ: FTLF), a Nevada‑incorporated developer and marketer of proprietary nutritional supplements and wellness products. Through these documents, investors can review the company’s official disclosures on financial performance, governance, compensation, and material events.
FitLife’s SEC filings include annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which present audited and interim financial statements, segment and brand‑level discussions, risk factors, and management’s analysis of results. Current reports on Form 8‑K disclose significant events such as quarterly earnings releases, entry into material definitive agreements, completion of acquisitions, changes in financing arrangements, and outcomes of the annual meeting of stockholders.
For example, Form 8‑K filings describe the approval and closing of the asset acquisition of Irwin Naturals, the associated Loan, Security and Guarantee Agreement with First‑Citizens Bank & Trust Company, and the related term loan and revolving credit facility. Other 8‑K filings detail the use of new corporate presentations, voting results for director elections, advisory votes on executive compensation, and ratification of independent auditors.
Proxy materials, such as the definitive proxy statement on Schedule 14A, outline board composition, committee memberships, executive and director compensation programs, and the matters submitted to shareholder vote at the annual meeting. Together, these filings give a structured view of FitLife’s capital structure, governance framework, acquisition activity, and financial obligations.
On Stock Titan, these filings are updated as they are made available on EDGAR, and AI-powered tools can help summarize lengthy documents, highlight key terms such as covenants in credit agreements, and surface important items from earnings-related 8‑Ks and proxy statements for quicker review.
FitLife Brands reported strong 2025 revenue growth but weaker profitability. Full-year revenue rose to $81.5M from $64.5M, helped by the Irwin acquisition, while net income fell to $6.3M from $9.0M as margins and expenses pressured earnings.
Gross margin declined to 38.6% from 43.6%, and adjusted EBITDA was roughly flat at $14.0M. In Q4 2025, revenue grew 73% to $25.9M, but gross margin slipped to 34.5%. The company ended 2025 with a term loan of $39.1M, revolver borrowings of $5.6M, and cash of $1.6M, and is prioritizing debt reduction.
Management highlighted persistent demand weakness across most brands in early 2026, but noted rapid online growth for Irwin, particularly on Amazon, where annualized revenue has reached an estimated $9–10M run rate.
FitLife Brands, Inc. filed its annual report describing a year of significant expansion driven by acquisitions and e‑commerce growth. The company bought substantially all assets of Irwin Naturals for $42.5 million, funded by a $29.75 million term loan, $6.0 million from a new $10.0 million revolver, and cash.
FitLife executed a 2‑for‑1 stock split on February 7, 2025, and ended the year with 9,391,072 common shares outstanding and non‑affiliate equity valued at $50.75 million. About 49% of 2025 sales came from Amazon’s U.S. marketplace and 14% from GNC’s centralized distribution, underscoring heavy channel concentration.
Total debt reached $44.7 million, mainly from deal financing, while headcount more than doubled to 81 employees, reflecting integration of acquired brands. The report highlights intense competition, regulatory exposure in nutrition and supplements, customer concentration risks, rising leverage, and cybersecurity oversight but notes no material legal proceedings or identified material cybersecurity incidents.
FitLife Brands furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is furnished under Items 2.02 and 7.01 as Exhibit 99.1 and, as stated, is not deemed “filed” under Section 18 and is not incorporated by reference unless specifically identified. The company’s common stock trades on the Nasdaq Capital Market under the symbol FTLF.
FitLife Brands reported third-quarter results and detailed its August acquisition of Irwin Naturals. Q3 revenue was $23,485, up 47% year over year, driven by the Irwin addition and growth at MusclePharm. Net income was $921 with diluted EPS of $0.09.
Gross margin declined to 37.2% from 43.8%, reflecting Irwin’s historically lower margins and a $392 inventory step-up amortization. Operating expenses rose on transaction costs ($820 in Q3). For the nine months, revenue reached $55,548 and net income was $4,686.
FitLife closed the Irwin deal for approximately $42,500, funded by a new $40,625 term loan and $6,000 drawn on a $10,000 revolver, both with SOFR-based rates. Covenants begin with the quarter ending Dec 31, 2025. To manage rate risk, the company entered a swap on Sep 5, 2025 fixing $20,000 notional at 3.39% to Aug 8, 2030. Shares outstanding were 9,391,072 as of Nov 12, 2025.
FitLife Brands, Inc. (FTLF) reported an insider transaction by CFO Jakob York showing a grant of stock options dated 09/05/2025. The option grant covers 4,000 stock options with an exercise price of $18.73 and an expiration date of 09/05/2030. One-fourth of the options vest immediately on the grant date and the remainder vests in three equal annual installments thereafter.
The filing is a Form 4, indicating a change in beneficial ownership by an officer. Following the grant, Mr. York beneficially owns 4,000 underlying common shares via the option, held directly. The form is signed and dated 09/08/2025.
FitLife Brands, Inc. furnished a new corporate presentation for business purposes. The company began using this updated Corporate Presentation on August 19, 2025, and made it available as Exhibit 99.1 to this report. The materials provide an overview of FitLife Brands but are furnished under Regulation FD, meaning they are not treated as formally filed financial statements or incorporated into other securities law filings unless specifically referenced.
FitLife Brands disclosed that it issued a press release announcing its financial results for the quarter ended June 30, 2025, and attached that release as Exhibit 99.1 to this Current Report. The company furnished the information under Items 2.02 and 7.01 and included a statement that the furnished materials are not to be deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference unless explicitly stated.
FitLife Brands reported quarterly revenue of $16.1 million (down 5% year-over-year) and six-month revenue of $32.1 million (down 4%). Net income was $1.75 million for Q2 and $3.77 million year-to-date, both below the prior-year periods as gross profit and margins declined. Cash and restricted cash totaled $1.585 million at June 30, 2025 and working capital was $9.2 million.
After the quarter the company closed a material acquisition of Irwin Naturals for approximately $42.5 million, funded largely by a new $40.625 million term loan and a new $10.0 million revolver; $29.75 million of the new term loan funded the acquisition and $10.875 million retired prior debt. The company implemented a 2-for-1 stock split and the Board authorized a $5.0 million share repurchase program.
FitLife Brands, Inc. reported the results of its 2025 Annual Meeting of Stockholders. All five nominated directors were elected by plurality, with vote tallies showing strong support: Dayton Judd 6,586,405 for / 4,528 withheld, Grant Dawson 6,516,060 for / 74,873 withheld, Matt Lingenbrink 6,523,190 for / 67,743 withheld, Seth Yakatan 6,425,713 for / 165,220 withheld, and Shannon Pappas 6,523,190 for / 67,743 withheld. Each will serve until the 2026 Annual Meeting.
Stockholders approved the non-binding advisory vote on executive compensation with 6,521,001 for / 64,922 against / 5,010 abstain. They selected a triennial frequency for future advisory votes on compensation (5,979,100 for 3 years), and ratified Weinberg & Company, P.A. as independent auditors for the 2025 fiscal year (8,161,128 for / 10 against / 6 abstain).
FitLife Brands completed a $42.5 million purchase of substantially all assets of Irwin Naturals and closed a financing package to fund the acquisition and retire prior debt. The company paid $37.5 million at closing after a $5.0 million deposit, funding the closing payment with $29.75 million of a five-year Term Loan and $6.0 million from a three-year $10.0 million revolving Credit Line, with the remainder from cash.
The Term Loan totals $40.625 million and carries a margin of 2.50%–3.00% above Term SOFR, amortizes through scheduled quarterly principal payments (3.75% of outstanding principal for the first eight payment dates, then 5.00%), and matures on August 8, 2030. The Credit Line matures August 8, 2028. The loan package includes customary defaults, subsidiary guarantees, and security interests in substantially all assets and imposes financial covenants including a Senior Funded Debt to EBITDA ratio step-down and a Fixed Charge Coverage Ratio of at least 1.25 tested quarterly.